Clene Nanomedicine News and Activities

Clene Nanomedicine is a company listed under the stock ticker CLNN (US).

View the org chart displaying its 19 main executives

Most searched biographies at Clene Nanomedicine

• Rob Etherington, Director, Chief Executive Officer and President
• Matthew Kiernan, Director
• David Matlin, Chairman of the Board

Create your alert
to follow the executive moves at Clene Nanomedicine.

Clene Nanomedicine has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Clene Nanomedicine

• Clene Reports Third Quarter 2023 Financial Results and Operating Highlights | Clene Inc.
• Clene Announces Peer-Reviewed Publication Describing CNM-Au8 Catalytic Neuroprotective Mechanism of Action | Clene Inc.
• National Institutes of Health Awards $45.1 Million NINDS Grant for CNM-Au8® Study in ALS | Clene Inc.
• Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference | Clene Inc.
• Clene Reports Significant Long-Term Survival Improvement From CNM-Au8 Treatment in HEALEY ALS Platform Trial Compared to PRO-ACT Historical Controls | Clene Inc.
• Clene Inc. - Press
• Clene Inc. - News & Events
• Clene Inc. - News & Events
• View more press releases Close

Social media about Clene Nanomedicine

• Clene Nanomedicine on Wikipedia, Google News & Yahoo Finance
• Clene Nanomedicine on LinkedIn, X (Twitter) & YouTube